Literature DB >> 25833017

Challenges and exciting new opportunities to advance personalized treatment for alcohol use disorder.

Howard C Becker1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25833017      PMCID： PMC4482353          DOI： 10.1111/acer.12664

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN： 0145-6008            Impact factor:   3.455


× No keyword cloud information.
  8 in total

1.  Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.

Authors:  Thomas Insel; Bruce Cuthbert; Marjorie Garvey; Robert Heinssen; Daniel S Pine; Kevin Quinn; Charles Sanislow; Philip Wang
Journal:  Am J Psychiatry       Date:  2010-07       Impact factor: 18.112

Review 2.  Personalized treatment of alcohol dependence.

Authors:  Henry R Kranzler; James R McKay
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 3.  Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.

Authors:  James C Garbutt; Amy M Greenblatt; Suzanne L West; Laura C Morgan; Alexei Kampov-Polevoy; Harmon S Jordan; Georgiy V Bobashev
Journal:  Addiction       Date:  2014-05-23       Impact factor: 6.526

4.  Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Authors:  Joseph P Schacht; Raymond F Anton; Konstantin E Voronin; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

5.  Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.

Authors:  Henry R Kranzler; Jonathan Covault; Richard Feinn; Stephen Armeli; Howard Tennen; Albert J Arias; Joel Gelernter; Timothy Pond; Cheryl Oncken; Kyle M Kampman
Journal:  Am J Psychiatry       Date:  2014-04       Impact factor: 18.112

6.  A genetic determinant of the striatal dopamine response to alcohol in men.

Authors:  V A Ramchandani; J Umhau; F J Pavon; V Ruiz-Velasco; W Margas; H Sun; R Damadzic; R Eskay; M Schoor; A Thorsell; M L Schwandt; W H Sommer; D T George; L H Parsons; P Herscovitch; D Hommer; M Heilig
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

7.  The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology.

Authors:  Bruce N Cuthbert
Journal:  World Psychiatry       Date:  2014-02       Impact factor: 49.548

8.  Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.

Authors:  Bankole A Johnson; Chamindi Seneviratne; Xin-Qun Wang; Nassima Ait-Daoud; Ming D Li
Journal:  Am J Psychiatry       Date:  2013-09       Impact factor: 18.112
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.